UCLA and Stanford Medicine researchers, in collaboration with scientists from the University of Utah and Columbia University, ...
The CAPTAIN trial shows faster recovery, fewer complications, and better early function with the minimally invasive therapy in men with intermediate-risk prostate cancer.
The Urocross Expander System is designed to remodel the obstructing prostatic lobes during the six-month indwell time and is intentionally retrieved, leaving no permanent foreign material behind.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results